Cargando…

Immediate reactions after mRNA SARS-CoV-2 vaccination

Detalles Bibliográficos
Autores principales:	Jeimy, Samira, Wong, Tiffany, Song, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Joule Inc. 2021
Materias:	Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648359/ https://www.ncbi.nlm.nih.gov/pubmed/34772737 http://dx.doi.org/10.1503/cmaj.211581

Ejemplares similares

Adverse cutaneous reactions after mRNA SARS-CoV-2 vaccination in 3 patients: a spectrum of severity
por: Edgerley, Sarah, et al.
Publicado: (2022)

Réactions immédiates après l’administration d’un vaccin à ARNm contre le SRAS-CoV-2
por: Jeimy, Samira, et al.
Publicado: (2022)

Persistent myopericarditis after heterologous SARS-CoV-2 mRNA vaccination
por: Wu, Kai Yi, et al.
Publicado: (2023)

Bacillus Calmette–Guérin scar flare after an mRNA SARS-CoV-2 vaccine
por: Lim, Darren Wan-Teck, et al.
Publicado: (2021)

Possible association between rhabdomyolysis and mRNA SARS-CoV-2 vaccination in a patient with RYR1 gene mutation
por: Salter, Brittany, et al.
Publicado: (2022)

Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines
por: Stehlin, Florian, et al.
Publicado: (2023)

SARS-CoV-2 vaccination in pregnancy
por: Dalcin, Daniel, et al.
Publicado: (2023)

Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines
por: Kelso, John M.
Publicado: (2021)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection
por: Vohra-Miller, Sabina, et al.
Publicado: (2022)

Shoulder injury related to SARS-CoV-2 vaccine administration
por: Chow, Jacky C.K., et al.
Publicado: (2022)

Functional neurologic disorder associated with SARS-CoV-2 vaccination
por: Zhu, Annie, et al.
Publicado: (2022)

Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2
por: Blumenthal, Kimberly G., et al.
Publicado: (2021)

Delayed Hypersensitivity Reactions Following First Dose of the SARS-CoV2 mRNA Vaccines
por: Xu, Jennifer, et al.
Publicado: (2021)

Réactions cutanées indésirables à des vaccins anti-SRAS-CoV-2 à ARNm chez 3 patients: spectre de gravité
por: Edgerley, Sarah, et al.
Publicado: (2022)

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines
por: Westreich, Aaron, et al.
Publicado: (2023)

Tick-borne red meat allergy (α-gal syndrome)
por: Jeimy, Samira, et al.
Publicado: (2023)

Symptomology following mRNA vaccination against SARS-CoV-2
por: Ebinger, Joseph E., et al.
Publicado: (2021)

Delayed skin reactions after the second dose of mRNA vaccines against SARS-CoV-2
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine
por: Bialasiewicz, A. A., et al.
Publicado: (2021)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

Accidental self-administration of an epinephrine autoinjector by a toddler
por: Edgerley, Sarah, et al.
Publicado: (2021)

SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
por: Ota, Mitsuhito
Publicado: (2022)

Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020)

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
por: Jackson, Lisa A., et al.
Publicado: (2020)

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
por: Yi, Changhua, et al.
Publicado: (2020)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
por: Bettini, Emily, et al.
Publicado: (2021)

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
por: Ali, Kashif, et al.
Publicado: (2021)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
por: Echaide, Miriam, et al.
Publicado: (2023)

The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2
por: Jamous, Yahya F, et al.
Publicado: (2023)

Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions
por: Klingel, Hanna, et al.
Publicado: (2023)

New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
por: Arismendez, Alan A., et al.
Publicado: (2023)

The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital
por: Paoletti, Giovanni, et al.
Publicado: (2023)

Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction
por: Hoff, Norman-Philipp, et al.
Publicado: (2021)

Immunogenicity of SARS‐CoV‐2 mRNA vaccine in solid organ transplant recipients
por: Holden, Inge K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v9io3eps863cnve7e5s8pp5ha9